Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$6.01
-0.350 (-5.50%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
May 13, 2022 $12.94 $14.16 $12.63 $13.73 835 182
May 12, 2022 $11.52 $12.69 $11.30 $12.39 757 877
May 11, 2022 $13.51 $13.89 $11.41 $11.64 910 347
May 10, 2022 $13.35 $14.08 $12.43 $13.39 993 646
May 09, 2022 $13.04 $13.34 $12.08 $12.18 810 469
May 06, 2022 $13.87 $13.92 $12.70 $13.19 636 793
May 05, 2022 $15.33 $15.82 $13.76 $14.17 589 971
May 04, 2022 $15.52 $15.76 $14.39 $15.74 743 429
May 03, 2022 $15.60 $16.11 $15.15 $15.42 560 202
May 02, 2022 $14.82 $15.63 $14.61 $15.52 796 525
Apr 29, 2022 $15.73 $16.57 $14.86 $14.92 387 057
Apr 28, 2022 $15.58 $16.17 $14.31 $15.78 649 059
Apr 27, 2022 $15.85 $16.48 $15.25 $15.39 478 921
Apr 26, 2022 $16.86 $17.38 $15.69 $15.84 637 152
Apr 25, 2022 $16.42 $17.80 $16.24 $16.93 670 233
Apr 22, 2022 $16.84 $17.23 $16.33 $16.51 503 100
Apr 21, 2022 $18.74 $18.75 $16.47 $16.99 661 500
Apr 20, 2022 $18.96 $18.96 $17.84 $18.36 392 100
Apr 19, 2022 $18.84 $19.10 $17.99 $18.92 818 400
Apr 18, 2022 $20.02 $20.52 $18.77 $18.93 505 100
Apr 14, 2022 $20.53 $21.71 $20.23 $20.33 354 171
Apr 13, 2022 $18.95 $21.28 $18.95 $21.01 545 157
Apr 12, 2022 $18.90 $19.88 $18.52 $18.94 305 812
Apr 11, 2022 $19.18 $19.65 $18.20 $18.46 518 141
Apr 08, 2022 $19.71 $20.44 $19.62 $19.72 56 492
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT